Imatinib Completed Phase 1 / 2 Trials for Acute Myelogenous Leukaemia (AML) / Agnogenic Myeloid Metaplasia / Chronic Myelogenous Leukemia (CML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00047502Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia